Nanox (NASDAQ: NNOX) announced that its subsidiary, Nanox AI Ltd., has entered into a distribution agreement with Technologic s.r.l., an Italian company affiliated with Tecnologie Avanzate, to commercialize its AI-powered bone health solution, HealthOST, in Italy. The agreement is intended to expand Nanox AI's commercial presence in the Italian market by leveraging Technologic's experience and local market knowledge.
HealthOST analyzes eligible routine CT scans to provide qualitative and quantitative assessments of the spine, helping clinicians identify patients who may benefit from further evaluation for musculoskeletal conditions such as osteoporosis. This matters because osteoporosis is often underdiagnosed until a fracture occurs, and by extracting bone health insights from scans already performed for other reasons, HealthOST aims to support earlier detection without requiring additional imaging sessions or radiation exposure.
The deal gives Nanox AI a local partner with established relationships in the Italian healthcare market. Technologic's affiliation with Tecnologie Avanzate provides distribution reach and market familiarity that could accelerate adoption of HealthOST among Italian radiology providers. For Nanox, the agreement represents a step in its broader strategy to commercialize AI-based solutions across Europe, following its focus on driving the transition to preventive health care through an integrated imaging and healthcare services platform. The company combines affordable imaging hardware, AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection and broader access to care.
Nanox AI is part of the Nanox ecosystem, which includes Nanox.ARC, a 3D multi-source digital tomosynthesis imaging system; Nanox.CLOUD, a cloud-based platform for secure data management and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings for remote radiology and teleradiology services; and Nanox Health IT for RIS, PACS, AI, and dictation solutions. The addition of an Italian distribution channel for HealthOST extends the reach of the company's AI algorithms, which are designed to augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease.
The agreement's significance lies in its potential to demonstrate the commercial viability of Nanox's AI offerings in a major European market. If HealthOST gains traction in Italy, it could serve as a reference case for expansion into other countries and for partnerships with regional distributors. The full press release is available at https://ibn.fm/y9Zro, and the latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. Additional information about Nanox is available through Nanox (NASDAQ: NNOX).
